Certified by Founder Lodge 
                                        
                                        Atsena Therapeutics
 
                                                 United States  -  Durham,NC 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $150,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2019
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Atsena Therapeutics is a clinical-stage gene therapy company developing novel treatments for inherited forms of blindness. The company has two clinical-stage programs, ATSN-201 for X-linked r
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| April, 07 ,2025 | Series C | $150,000,000 | 
                                                
 Hatteras Venture Partners
                                                                                
 Bain Capital
                                                                                
 Lightstone Ventures
                                                                                
 Wellington Management
                                                                                
 Osage University Partners (OUP)
                                                                                
 Abingworth
                                                                                
                                                                            
 Sofinnova Investments
                                                                                
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025)